These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33587820)

  • 21. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.
    Paolillo A; Pozzilli C; Gasperini C; Giugni E; Mainero C; Giuliani S; Tomassini V; Millefiorini E; Bastianello S
    J Neurol Sci; 2000 Mar; 174(2):85-91. PubMed ID: 10727693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis.
    Abel S; Vavasour I; Lee LE; Johnson P; Ristow S; Ackermans N; Chan J; Cross H; Laule C; Dvorak A; Schabas A; Hernández-Torres E; Tam R; Kuan AJ; Morrow SA; Wilken J; Rauscher A; Bhan V; Sayao AL; Devonshire V; Li DKB; Carruthers R; Traboulsee A; Kolind SH
    JAMA Netw Open; 2020 Sep; 3(9):e2014220. PubMed ID: 32990740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corpus callosum atrophy as a marker of clinically meaningful cognitive decline in secondary progressive multiple sclerosis. Impact on employment status.
    Papathanasiou A; Messinis L; Zampakis P; Papathanasopoulos P
    J Clin Neurosci; 2017 Sep; 43():170-175. PubMed ID: 28601572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corpus callosum atrophy and post-surgical seizures in temporal lobe epilepsy associated with hippocampal sclerosis.
    Uribe-San-Martín R; Ciampi E; Di Giacomo R; Vásquez M; Cárcamo C; Godoy J; Lo Russo G; Tassi L
    Epilepsy Res; 2018 May; 142():29-35. PubMed ID: 29549794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis.
    Fujimori J; Nakashima I
    J Neuroimmunol; 2024 Feb; 387():578280. PubMed ID: 38171046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between corpus callosum damage, clinical disability, and surface-based homologous inter-hemispheric connectivity in multiple sclerosis.
    Russo AW; Stockel KE; Tobyne SM; Ngamsombat C; Brewer K; Nummenmaa A; Huang SY; Klawiter EC
    Brain Struct Funct; 2022 Dec; 227(9):2909-2922. PubMed ID: 35536387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical MRI disease activity influences cognitive performance in MS patients.
    Damasceno A; Damasceno BP; Cendes F
    Mult Scler Relat Disord; 2015 Mar; 4(2):137-43. PubMed ID: 25787189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis.
    Lin X; Tench CR; Morgan PS; Constantinescu CS
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):437-41. PubMed ID: 17673493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing easy to perform routine MRI measurements as potential surrogates for cognitive impairment in MS.
    Morrow SA; Menon S; Rosehart H; Sharma M
    Clin Neurol Neurosurg; 2017 Feb; 153():73-78. PubMed ID: 28061362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
    Llufriu S; Blanco Y; Martinez-Heras E; Casanova-Molla J; Gabilondo I; Sepulveda M; Falcon C; Berenguer J; Bargallo N; Villoslada P; Graus F; Valls-Sole J; Saiz A
    PLoS One; 2012; 7(5):e37167. PubMed ID: 22606347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between retinal nerve fibre layer thickness and corpus callosum index in different clinical subtypes of multiple sclerosis.
    Cilingir V; Batur M; Bulut MD; Milanlioglu A; Yılgor A; Batur A; Yasar T; Tombul T
    Neurol Sci; 2017 Jul; 38(7):1223-1232. PubMed ID: 28396954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging.
    Simon JH; Schiffer RB; Rudick RA; Herndon RM
    AJNR Am J Neuroradiol; 1987; 8(4):599-604. PubMed ID: 3113196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.
    Pelletier J; Suchet L; Witjas T; Habib M; Guttmann CR; Salamon G; Lyon-Caen O; Chérif AA
    Arch Neurol; 2001 Jan; 58(1):105-11. PubMed ID: 11176943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
    J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive dysfunction and brain atrophy in Susac syndrome.
    Machado S; Jouvent E; Klein I; De Guio F; Machado C; Cohen-Aubart F; Sacré K; Papo T
    J Neurol; 2020 Apr; 267(4):994-1003. PubMed ID: 31828475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging.
    Storelli L; Azzimonti M; Gueye M; Vizzino C; Preziosa P; Tedeschi G; De Stefano N; Pantano P; Filippi M; Rocca MA
    Invest Radiol; 2022 Jul; 57(7):423-432. PubMed ID: 35093968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis.
    Figueira FF; Santos VS; Figueira GM; Silva AC
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):931-5. PubMed ID: 18094848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study.
    Kalincik T; Vaneckova M; Tyblova M; Krasensky J; Seidl Z; Havrdova E; Horakova D
    PLoS One; 2012; 7(11):e50101. PubMed ID: 23166826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Callosal circularity as an early marker for Alzheimer's disease.
    Van Schependom J; Niemantsverdriet E; Smeets D; Engelborghs S
    Neuroimage Clin; 2018; 19():516-526. PubMed ID: 29984160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced choroid plexus segmentation with 3D UX-Net and its association with disease progression in multiple sclerosis.
    Wang X; Wang X; Yan Z; Yin F; Li Y; Liu X; Liu Y
    Mult Scler Relat Disord; 2024 Aug; 88():105750. PubMed ID: 38986172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.